✦ LIBER ✦

O-28 SYSTEMIC CHEMOTHERAPY AND G-CSF COMBINATION METHOD FOR THE HEMATOPOIETIC STEM CELL MOBILIZATION

✍ Scribed by S. Civriz Bozdag; I. Sirinoglu Demiriz; A.I. Emre Tekgunduz; A. Yurtcu; O. Kayikci; A. Tetik; S. Namdaroglu; B. Ugur; G. Durgun; F. Altuntas

Book ID: 119612914
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 62 KB
Volume: 47
Category: Article
ISSN: 1473-0502
DOI: 10.1016/s1473-0502(12)70029-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plerixafor plus G-CSF in combination wit

Plerixafor plus G-CSF in combination with chemotherapy for stem cell mobilization in a pediatric patient with Ewing's sarcoma

✍ Susana Vives; Juan-Manuel Sancho; Francisco Almazán; Jordi Juncà; Joan-Ramon Gri 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

Plerixafor and granulocyte–colony-stimul

Plerixafor and granulocyte–colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program

✍ Nina Worel; Konrad Rosskopf; Peter Neumeister; Hedwig Kasparu; David Nachbaur; G 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 303 KB

126-P: Randomized trial comparing G-CSF

126-P: Randomized trial comparing G-CSF vs. the combination of GM-CSF/G-CSF for mobilization of CD34+ and dendritic cell subsets in hematopoietic progenitor cell products in children with malignant diseases

✍ Nilka Barrios; Mayra Ortiz; Maria Echevarria; Roman Velez 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Mobilized CD34+ cells as a biomarker can

Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer

✍ Sang Joon Shin; Hei-Cheul Jeung; Joong Bae Ahn; Sun Young Rha; Nae Choon Yoo; Ja 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Despite the Use of the Combination of G-

Despite the Use of the Combination of G-CSF and Plerixafor for Stem Cell Mobilization, One Third of the Patients with Lymphoma Were Still “Poor Mobilizer” Using the Criteria Recently Proposed by GITMO (< 2.0 X 106 CD 34 + Cells Per Kg in ≤ 3 Apheresis)

✍ H.C. Fung; J. Tornatta; B. McLeod; S. Nathan; J. Maciejewski; E. Rich; R. Karmal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

The VAD chemotherapy regimen plus a G-CS

The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients

✍ Audat, F; Suarez, F; Hermine, O; Damaj, G; Maillard, N; Ribeil, J A; Lefrère, F; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 122 KB